Results 111 to 120 of about 3,561,997 (213)

PB2626: THROMBOPOIETIN RECEPTOR AGONISTS FOR RESISTANT THROMBOCYTOPENIA IN PREGNANCY A CASE SERIES AND REVIEW OF LITERATURE

HemaSphere, 2023
Gamal Sayed, Sarah Elkourashy, Dina Soliman, Naela Al Mallahi, Awni Alshurafa, Amna Gamil, Firyal Ibrahim, Mohammed Alnajjar, Shehab Mohamed   +8 more
doaj   +1 more source

Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis. [PDF]

J Thorac Dis, 2021
Ma H, Cheng J, Yu Y, Liu B, Qin J, Xing W, Luo S.   +6 more
europepmc   +1 more source

Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B Study. [PDF]

PURPOSE: The absence of postoperative circulating tumor DNA (ctDNA) identifies patients with resected colorectal cancer (CRC) with low recurrence risk for adjuvant chemotherapy (ACT) de-escalation.
Raja, A, Branagan, G, Peckitt, C, Gupta, A, TRACC Part B trial investigators,, Slater, S, Melcher, L, Bucheit, L, Cunningham, D, Bryant, A, Anandappa, G, West, N, Lazaro-Alcausi, R, Khakoo, S, Marti, FM, Aresu, M, Duff, S, Potter, V, Starling, N, Rich, T, Begum, R, Chen, H-C, Carter, P, Huang, J, Chau, I, Abulafi, M, George, N   +26 more
core   +1 more source

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial [PDF]

, 2020
BACKGROUND: 10-year results from several studies showed improved disease-free survival and distant metastasis-free survival, reduced breast cancer-related mortality, and variable effects on overall survival with the addition of partial or comprehensive ...
European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups
core  

Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort study

Journal for ImmunoTherapy of Cancer
Background Immune checkpoint inhibitors (ICIs) have led to enduring responses in subsets of patients with cancer. However, these responses carry the risk of immune-related adverse events (irAEs), which can diminish the overall benefit of ICI treatment ...
Lisa H Butterfield, John E Connolly, Nicholas L Bayless, Jeffrey A Bluestone, Samantha Bucktrout, Aik Choon Tan, Kevan C Herold, Zoe Quandt, Anastasia Lucas, Arabella Young, Christine N Spencer, Lacey J Padron, Samantha I Liang, EnJun Yang, Samantha Stone, Muhammad Zaki Hidayatullah Fadlullah, Sara Siebel Marr, Marshall A Thompson, Mark S Anderson   +18 more
doaj   +1 more source

Identification of Tumor Microenvironment-Related Prognostic Biomarkers for Ovarian Serous Cancer 3-Year Mortality Using Targeted Maximum Likelihood Estimation: A TCGA Data Mining Study. [PDF]

Front Genet, 2021
Wang L, Sun X, Jin C, Fan Y, Xue F.
europepmc   +1 more source

Immune checkpoint inhibitor-related myocarditis during DUO-E regimen for endometrial cancer: The first case report in gynecologic oncology

Gynecologic Oncology Reports
Background: Immune checkpoint inhibitors (ICIs) are increasingly used in gynecologic oncology, with the DUO-E regimen—carboplatin, paclitaxel, and durvalumab—recently approved in Japan for advanced or recurrent endometrial cancer.
Eri Yamabe, Hironori Yamamoto, Keita Asano, Taku Yasui, Masashi Fujita, Tsuyoshi Hisa, Miho Kitai   +6 more
doaj   +1 more source

Inverse effects of mucin on survival of matched hereditary nonpolyposis colorectal cancer and sporadic colorectal cancer patients [PDF]

, 2008
[[abstract]]Purpose: To compare survival and histologic features of hereditary nonpolyposis colorectal cancer (HNPCC; Lynch syndrome) cases to well-matched sporadic colon cancers from the same patient population. Experimental Design: Between January 1995
You, JF; Hsieh, LL; Changchien, CR; Chen, JS; Chen, JR; Chiang, JM; Yeh, CY; Hsieh, PS; Fan, CW; Liu, CT; Tang, R
core  

A case of pelvic EWSR1-PATZ1 fusion sarcoma treated with carbon ion radiotherapy

Radiology Case Reports
EWSR1-PATZ1 fusion sarcoma is a type of round-cell sarcoma with EWSR1-non-EST fusion that was newly categorized in the 2020 World Health Organization classification of soft tissue and bone tumors.
Toshinari Yagi, MD, Osamu Suzuki, PhD, Haruki Matsuoka, MD, Kei Shinyashiki, MD, Toru Wakamatsu, MD, PhD, Hironari Tamiya, MD, PhD, Rie Suzuki, MD, Shigeki Kakunaga, MD, PhD, Satoshi Takenaka, MD, PhD, Yoshiko Hashii, MD, PhD, Ken-ichi Yoshida, MD, PhD, Katsuyuki Nakanishi, MD, PhD   +11 more
doaj   +1 more source

Catheter embolization for pulmonary arteriovenous malformations during chemotherapy for appendiceal adenocarcinoma: A case report of associated brain abscess

Radiology Case Reports
Pulmonary arteriovenous malformations are rare, abnormal, low-resistance vascular structures that connect a pulmonary artery to a vein. They are common in patients with hereditary hemorrhagic telangiectasia; however, acquired malformations can occur in ...
Toshinari Yagi, MD, Koji Takano, MD, PhD, Toru Umehara, MD, PhD, Hideyuki Arita, MD, PhD, Noboru Maeda, MD, PhD, Katsuyuki Nakanishi, MD, PhD   +5 more
doaj   +1 more source